MetaboMed Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors (NCT04990739) | MetaboMed Inc | 2021-06-30 |
Track MetaboMed Inc automatically
Every clearance here is in the API, with alerts when new ones post.